Bajaj Healthcare Ltd
BAJAJHCAREBajaj Healthcare Ltd
BAJAJHCARE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -36.76 | 2.84 | 0.26% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.91 | 6.52 | 0.49% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of bulk drugs and pharmaceutical products. The Company's segments include manufacturing of Bulk Drugs, and Formulation and sale of medicines.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 223.22 | 233.04 | 329.18 | 371.14 | 416.54 | 663.89 | 681.33 | 674.89 | 482.10 | 487.33 | ||||||||||
Raw Materials | 128.77 | 131.50 | 215.43 | 245.33 | 268.32 | 377.19 | 409.91 | 428.44 | 510.95 | 458.43 | ||||||||||
| Power & Fuel Cost | 14.12 | 16.79 | 19.81 | 21.83 | 24.24 | 24.96 | 31.83 | 41.46 | ||||||||||||
| Employee Cost | 16.93 | 19.57 | 21.65 | 24.62 | 28.18 | 34.55 | 41.11 | 47.84 | ||||||||||||
| Selling & Administrative Expenses | 6.01 | 5.68 | 5.68 | 7.31 | 8.00 | 12.91 | 14.86 | 15.73 | ||||||||||||
| Operating & Other expenses | 26.96 | 26.28 | 25.10 | 28.16 | 32.98 | 71.00 | 63.52 | 32.86 | ||||||||||||
EBITDA | 30.43 | 33.22 | 41.51 | 43.89 | 54.82 | 143.28 | 120.10 | 108.56 | -28.85 | 28.90 | ||||||||||
| Depreciation/Amortization | 9.29 | 11.35 | 11.08 | 11.41 | 12.12 | 16.12 | 17.64 | 27.36 | 27.62 | 28.04 | ||||||||||
| PBIT | 21.14 | 21.87 | 30.43 | 32.48 | 42.70 | 127.16 | 102.46 | 81.20 | -56.47 | 0.86 | ||||||||||
| Interest & Other Items | 7.64 | 8.20 | 7.73 | 8.32 | 6.63 | 8.34 | 12.78 | 22.99 | 29.68 | 29.36 | ||||||||||
| PBT | 13.50 | 13.67 | 22.70 | 24.16 | 36.07 | 118.82 | 89.68 | 58.21 | -86.15 | -28.50 | ||||||||||
| Taxes & Other Items | 5.29 | 5.87 | 7.50 | 7.86 | 10.82 | 35.71 | 18.30 | 15.19 | -2.35 | -0.07 | ||||||||||
| Net Income | 8.21 | 7.80 | 15.20 | 16.30 | 25.25 | 83.11 | 71.38 | 43.02 | -83.80 | -28.43 | ||||||||||
| EPS | 2.28 | 1.43 | 2.75 | 2.95 | 4.57 | 15.06 | 17.24 | 15.59 | -30.36 | -10.30 | ||||||||||
| DPS | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 1.38 | 1.50 | 1.00 | 1.00 | 1.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 | 0.09 | 0.09 | 0.06 | — | -0.10 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Bajaj Healthcare Ltd | -12.47 | 2.84 | 0.26% |
| Sun Pharmaceutical Industries Ltd | 45.71 | 6.52 | 0.74% |
| Cipla Ltd | 31.57 | 4.85 | 0.81% |
| Torrent Pharmaceuticals Ltd | 69.81 | 16.87 | 0.82% |
Price Comparison
Compare BAJAJHCARE with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 22, 2022
Dividend/Share
₹1.50
Ex DateEx Date
Sep 22, 2022
Cash Dividend
Ex DateEx DateSep 28, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 28, 2021
Cash Dividend
Ex DateEx DateSep 28, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 28, 2021
Cash Dividend
Ex DateEx DateSep 28, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 28, 2021
Net profit of Bajaj Healthcare reported to Rs 7.13 crore in the quarter ended June 2024 as against net loss of Rs 48.21 crore during the previous quarter ended June 2023. Sales rose 1.93% to Rs 132.25 crore in the quarter ended June 2024 as against Rs 129.74 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales132.25129.74 2 OPM %18.5316.76 - PBDT16.9113.22 28 PBT10.186.91 47 NP7.13-48.21 LP Powered by Capital Market - Live
Bajaj Healthcare will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Bajaj Healthcare Shares Soar 16% On API Deals With U.K., EU Clients
Stocks to watch on June 30, 2023
Sensex dives over 500 points: Rs 1.25L cr investor wealth lost; KRBL, Rhi Magnesita & Campus Activewear down up to 9%
Bajaj Healthcare standalone net profit declines 36.68% in the December 2022 quarter
Bajaj Healthcare Completes USFDA Pre-Approval Inspection Of Vadodara Plant
Bajaj Healthcare successfully completes USFDA pre-approval inspection of Vadodara plant
Bajaj Healthcare: Weak Q1 not a dampener for long run
In historic decision, India opens opium market to private players; Bajaj Healthcare first aboard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 5.37%, vs industry avg of 9.18%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.16% to 0.13%